[en] Myxomatosis is a specific disease of the European rabbit (Oryctolagus cuniculus) due to a virus belonging to the genus Leporipoxvirus. Forty-seven years after its deliberate introduction into Europe, the clinical aspects and the epizootiology of myxomatosis have changed. Two forms (nodular and amyxomatous) of the disease have been identified to date. A comparative study was made of the clinical signs, pathogenesis and gross lesions observed in male specific pathogen-free New Zealand White rabbits inoculated with five strains of amyxomatous myxoma virus. All five strains induced the characteristic amyxomatous myxomatosis clinical syndrome with clinical signs that differed only in intensity. The varying clinical intensity, together with the results of virological examination question the virulence of at least three of the five strains. Genomic analysis confirmed that the five strains came from the Lausanne strain introduced in 1952 in France and not from an unnoticed introduction of a Californian strain of myxoma virus. No link was found between the amyxomatous myxoma virus strains and the SG33 vaccine strain. 1999 Harcourt Publishers Ltd.
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Marlier, Didier ; Université de Liège - ULiège > Médecine des oiseaux, des lagomorphes et des rongeurs
Cassart, Dominique ; Université de Liège - ULiège > Département de morphologie et pathologie > Département de morphologie et pathologie
Boucraut-Baralon, C.
Coignoul, Freddy ; Université de Liège - ULiège > Département de morphologie et pathologie > Pathologie générale et autopsies
Vindevogel, Henri ; Université de Liège - ULiège > Services généraux (Faculté de médecine vétérinaire) > Relations académiques et scientifiques (Méd. vétérinaire)
Language :
English
Title :
Experimental Infection of Specific Pathogen-Free New Zealand White Rabbits with Five Strains of Amyxomatous Myxoma Virus
Arthur C. P., Louzis C. A review of myxomatosis among rabbits in France. Revue Scientifique et Technique de l'Office International des Epizooties. 7, (1988);937-976.
Bertagnoli S., Gelfi J., Le Gall G., Boilletot E., Vautherot J. F., Rasschaert D., Laurent S., Petit F., Boucraut-Baralon C., Milon A. Protection against myxomatosis and viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein. Journal of Virology. 70, (1996);5061-5066.
Brun A., Saurat P., Gilbert Y., Godart A., Bouquet J. F. Données actuelles sur l'épidémiologie, la pathogénie et la symptomatologie de la myxomatose. Revue de Médecine Vétérinaire. 132, (1981);585-590.
Fenner F. Myxoma virus. In Virus Infections of Vertebrates, Vol. 5, Virus Infections of Rodents and Lagomorphs, A. D. M. E. Osterhaus, Ed. Elsevier Science B. VAmsterdam, pp. (1994);59-71.
Fenner F., Marshall I. D., Woodroofe G. M. Studies in the epidemiology of infectious myxomatosis of rabbits: 1. Recovery of Australian wild rabbits (Oryctolagus cuniculus) from myxomatosis under field conditions. Journal of Hygiene, Cambridge. 51, (1953);225-244.
Fenner F., Ratcliffe F. N. Myxomatosis. Cambridge University Press, Cambridge. (1965).
Fenner F., Woodroofe G. M. The pathogenesis of infectious myxomatosis: the mechanism of infection and the immunological response in the European rabbit(Oryctolagus cuniculus). British Journal of Experimental Pathology. 34, (1953);400-411.
Graham K. A., Opgenorth A., Upton C., McFadden G. Myxoma virus M11L ORF encodes a protein for which cell surface localization is critical in manifestation of viral virulence. Virology. 191, (1992);112-124.
Guerin J. L., Petit F., Van Es A., Gelfi J., Py R., Bertagnoli S., Boucraut-Baralon C. Analyse moléculaire des souches vaccinales SG33 et Poxlap du virus myxomateux: implications prophylactiques et épidémiologiques. In 7esJournées de la Recherche Cunicole en France, Lyon 13-14 Mai 1998, Institut Technique de l'Aviculture, 28 Rue du Rocher, 75008 Paris, pp. (1998);53-56.
Joubert L., Duclos P. H., Tuaillon P. La myxomatose des garennes dans le Sud-Est: la myxomatose amyxomateuse. Revue de Médecine Vétérinaire. 133, (1982);739-753.
Kerr P. J. An ELISA for epidemiological studies of myxomatosis: persistence of antibodies to myxoma virus in European rabbits (Oryctolagus cuniculus). Wildlife Research. 24, (1997);53-65.
Marlier D., Boucraut-Baralon C., Vindevogel H. Diagnosis of myxomatosis by an indirect immunoperoxidase test. Vlaams Diergeneeskundig Tijdschrift, in press. (1999).
Marlier D., Coignoul F., Boucraut-Baralon C., Vindevogel H. Etude clinique et anatomopathologique de l'infection expérimentale de lapins par une souche virale amyxomateuse isolée en Belgique. Annales de Médecine Vétérinaire. 141, (1997);479-486.
Marlier D., Vindevogel H. La myxomatose amyxomateuse: isolement de trois souches en Belgique. Annales de Médecine Vétérinaire. 140, (1996);343-346.
Marshall I. D. The influence of ambient temperature on the course of myxomatosis in the rabbit. Journal of Hygiene, London. 57, (1959);484-497.
McFadden G., Graham K. Modulation of cytokine networks by poxvirus: the myxoma virus model. Seminars in Virology. 5, (1994);421-429.
McFadden G., Graham K., Ellison K., Barry M., Macen J., Schreiber M., Mossman K., Nash P., Lalani A., Everett H. Interruption of cytokine networks by poxviruses: lessons from myxoma virus. Journal of Leukocyte Biology. 57, (1995);731-738.
Messud-Petit F., Gelfi J., Delverdier M., Amardeilh M. F., Py R., Sutter G., Bertagnoli S. Serp 2, an inhibitor of the interleukin-1β-converting enzyme, is critical in the pathobiology of myxoma virus. Journal of Virology. 72, (1998);7830-7839.
Opgenorth A., Graham K., Nation N., Strayer D., McFadden G. Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. Journal of Virology. 66, (1992);4720-4731.
Petit F., Bertagnoli S., Gelfi J., Fassy F., Boucraut-Baralon C., Milon A. Characterization of a myxoma virus-encoded serpin-like protein with activity against interleukin-1β-converting enzyme. Journal of Virology. 70, (1996a);5860-5866.
Petit F., Boucraut-Baralon C., Py R., Bertagnoli S. Analysis of myxoma virus genome using pulsed field gel electrophoresis. Veterinary Microbiology. 50, (1996b);27-32.
Reed L. J., Muench H. A simple method for estimating fifty percent endpoints. American Journal of Hygiene. 27, (1938);493-497.
Saurat P., Gilbert Y., Ganière J. P. Etude d'une souche de virus myxomateux modifié Revue de Médecine Vétérinaire. 129, (1978);415-451.
